Bio-Techne
TECH
#1660
Rank
ยฃ8.16 B
Marketcap
ยฃ51.66
Share price
-0.47%
Change (1 day)
-7.25%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : ยฃ0.46 Billion

According to Bio-Techne's latest financial reports the company's total liabilities are ยฃ0.46 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30ยฃ0.53 B8.87%
2022-06-30ยฃ0.48 B-2.05%
2021-06-30ยฃ0.49 B-4.83%
2020-06-30ยฃ0.52 B-7.27%
2019-06-30ยฃ0.56 B45.47%
2018-06-30ยฃ0.38 B-16.78%
2017-06-30ยฃ0.46 B151.64%
2016-06-30ยฃ0.18 B35.12%
2015-06-30ยฃ0.13 B248.58%
2014-06-30ยฃ39.46 M48.03%
2013-06-30ยฃ26.66 M-6.81%
2012-06-30ยฃ28.6 M45.78%
2011-06-30ยฃ19.62 M72.27%
2010-06-30ยฃ11.39 M20.84%
2009-06-30ยฃ9.42 M-7.17%
2008-06-30ยฃ10.15 M18.25%
2007-06-30ยฃ8.58 M-47.36%
2006-06-30ยฃ16.31 M6.61%
2005-06-30ยฃ15.3 M-0.65%
2004-06-30ยฃ15.4 M-4.76%
2003-06-30ยฃ16.17 M-21.89%
2002-06-30ยฃ20.7 M-22.62%
2001-06-30ยฃ26.75 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ40.43 B 8,560.62%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.45 B 426.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ23.23 B 4,877.09%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ23.11 B 4,851.58%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.16 B 362.92%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ81.69 B 17,397.79%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ21.79 M-95.33%๐Ÿ‡บ๐Ÿ‡ธ USA